Skip to content

Predictive value of Magnetic Resonance Imaging (MRI), positron emission tomography (PET), and microemboli detection for stroke

Predictive value of Magnetic Resonance Imaging (MRI), positron emission tomography (PET), and microemboli detection for stroke - Predictive value for stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31611
Enrollment
278
Registered
2007-03-20
Start date
2007-04-16
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerotic plaques hardening of the arteries

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with neurological symptoms due to ischemia in the carotid artery territory and with a carotid stenosis between 30% and 69% as detected by US will be included (n

Exclusion criteria

Exclusion criteria: -Patients with evident other cause of neurological symptoms than carotid stenosis. -Patients that are already scheduled for carotid endarterectomy or stenting -Patients that are already scheduled for an intervention that is associated with embolization. -Severe co-morbidity, amaorosis Fugax, dementia, or pregnancy. -Standard contra-indications for MRI (ferromagnetic implants such as pacemakers and other implanted electrical devices, metallic fragments in the eyes, surgical vessel clips, claustrophobia, documented allergy to contrast media etc).

Design outcomes

Primary

MeasureTime frame
Primary endpoint is ipsilateral recurrent ischemic stroke alone.

Secondary

MeasureTime frame
Secondary endpoints are the combined endpoint of ipsilateral ischemic stroke and ipsilateral TIA, and the combined endpoint of ipsilateral ischemic stroke, ipsilateral TIA, and ipsilateral silent infarct as detected on brain MRI. Another secondary endpoint is the influence of patient positioning in the MRI scanner on results of plaque morphology and composition analyses.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)